These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38909641)
21. Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report. Namløs HM; Zaikova O; Bjerkehagen B; Vodák D; Hovig E; Myklebost O; Boye K; Meza-Zepeda LA BMC Cancer; 2017 Jan; 17(1):29. PubMed ID: 28061772 [TBL] [Abstract][Full Text] [Related]
22. Synchronous endometrial and ovarian cancer: A case report. Žilovič D; Čiurlienė R; Šidlovska E; Vaicekauskaitė I; Sabaliauskaitė R; Jarmalaitė S World J Clin Cases; 2023 Jun; 11(18):4341-4349. PubMed ID: 37449219 [TBL] [Abstract][Full Text] [Related]
23. Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer. Chao A; Chen SJ; Chen HC; Tan KT; Hsiao W; Jung SM; Yang LY; Huang KG; Chou HH; Huang HJ; Chang TC; Chao AS; Lee YH; Wu RC; Lai CH Biomed J; 2023 Oct; 46(5):100563. PubMed ID: 36208860 [TBL] [Abstract][Full Text] [Related]
24. FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring. Groeneweg JW; Roze JF; Peters EDJ; Sereno F; Brink AGJ; Paijens ST; Nijman HW; van Meurs HS; van Lonkhuijzen LRCW; Piek JMJ; Lok CAR; Monroe GR; van Haaften GW; Zweemer RP Gynecol Oncol; 2021 Aug; 162(2):413-420. PubMed ID: 34083028 [TBL] [Abstract][Full Text] [Related]
25. Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer. Sivapalan L; Thorn GJ; Gadaleta E; Kocher HM; Ross-Adams H; Chelala C BMC Cancer; 2022 Apr; 22(1):369. PubMed ID: 35392854 [TBL] [Abstract][Full Text] [Related]
26. Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis. Chidharla A; Rapoport E; Agarwal K; Madala S; Linares B; Sun W; Chakrabarti S; Kasi A Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373376 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the somatic mutations between circulating tumor DNA and tissue DNA in Chinese patients with non-small cell lung cancer. Zhang M; Feng Y; Qu C; Meng M; Li W; Ye M; Li S; Li S; Ma Y; Wu N; Jia S Int J Biol Markers; 2022 Dec; 37(4):386-394. PubMed ID: 35791673 [TBL] [Abstract][Full Text] [Related]
28. Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer. Gao Z; Huang D; Chen H; Yang Y; An K; Ding C; Yuan Z; Zhai Z; Niu P; Gao Q; Cai J; Zeng Q; Wang Y; Hong Y; Rong W; Huang W; Lei F; Wang X; Chen S; Zhao X; Bai Y; Gu J J Transl Med; 2023 Jan; 21(1):63. PubMed ID: 36717891 [TBL] [Abstract][Full Text] [Related]
29. Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer. Gale D; Heider K; Ruiz-Valdepenas A; Hackinger S; Perry M; Marsico G; Rundell V; Wulff J; Sharma G; Knock H; Castedo J; Cooper W; Zhao H; Smith CG; Garg S; Anand S; Howarth K; Gilligan D; Harden SV; Rassl DM; Rintoul RC; Rosenfeld N Ann Oncol; 2022 May; 33(5):500-510. PubMed ID: 35306155 [TBL] [Abstract][Full Text] [Related]
30. High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer. Ashley CW; Selenica P; Patel J; Wu M; Nincevic J; Lakhman Y; Zhou Q; Shah RH; Berger MF; Da Cruz Paula A; Brown DN; Marra A; Iasonos A; Momeni-Boroujeni A; Alektiar KM; Long Roche K; Zivanovic O; Mueller JJ; Zamarin D; Broach VA; Sonoda Y; Leitao MM; Friedman CF; Jewell E; Reis-Filho JS; Ellenson LH; Aghajanian C; Abu-Rustum NR; Cadoo K; Weigelt B Clin Cancer Res; 2023 Jan; 29(2):410-421. PubMed ID: 36007103 [TBL] [Abstract][Full Text] [Related]
31. Detection of epidermal growth factor receptor ( Guo K; Shao C; Han L; Liu H; Ma Z; Yang Y; Feng Y; Pan M; Santarpia M; Carmo-Fonseca M; Silveira C; Lee KY; Han J; Li X; Yan X Transl Lung Cancer Res; 2021 Jul; 10(7):3213-3225. PubMed ID: 34430359 [TBL] [Abstract][Full Text] [Related]
32. Genomic Landscape of ctDNA and Real-World Outcomes in Advanced Endometrial Cancer. Soberanis Pina P; Clemens K; Bubie A; Grant B; Haynes G; Zhang N; Drusbosky L; Lheureux S Clin Cancer Res; 2024 Dec; 30(24):5657-5665. PubMed ID: 39417689 [TBL] [Abstract][Full Text] [Related]
33. Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer. Han MR; Lee SH; Park JY; Hong H; Ho JY; Hur SY; Choi YJ Cancer Res Treat; 2020 Jul; 52(3):779-788. PubMed ID: 32106643 [TBL] [Abstract][Full Text] [Related]
34. Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer. Waldeck S; Mitschke J; Wiesemann S; Rassner M; Andrieux G; Deuter M; Mutter J; Lüchtenborg AM; Kottmann D; Titze L; Zeisel C; Jolic M; Philipp U; Lassmann S; Bronsert P; Greil C; Rawluk J; Becker H; Isbell L; Müller A; Doostkam S; Passlick B; Börries M; Duyster J; Wehrle J; Scherer F; von Bubnoff N Mol Oncol; 2022 Jan; 16(2):527-537. PubMed ID: 34653314 [TBL] [Abstract][Full Text] [Related]
35. Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study. Zhu GQ; Liu WR; Tang Z; Qu WF; Fang Y; Jiang XF; Song SS; Wang H; Tao CY; Zhou PY; Huang R; Gao J; Sun HX; Ding ZB; Peng YF; Dai Z; Zhou J; Fan J; Shi YH Mol Oncol; 2022 Jan; 16(2):549-561. PubMed ID: 34543520 [TBL] [Abstract][Full Text] [Related]
36. Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancer. Tan AC; Lai GGY; Saw SPL; Chua KLM; Takano A; Ong BH; Koh TPT; Jain A; Tan WL; Ng QS; Kanesvaran R; Rajasekaran T; Kalashnikova E; Renner D; Sudhaman S; Malhotra M; Sethi H; Liu MC; Aleshin A; Lim WT; Tan EH; Skanderup AJ; Ang MK; Tan DSW Cancer; 2024 May; 130(10):1758-1765. PubMed ID: 38422026 [TBL] [Abstract][Full Text] [Related]
37. Assessment of postoperative circulating tumour DNA to predict early recurrence in patients with stage I-III right-sided colon cancer: prospective observational study. Lygre KB; Forthun RB; Høysæter T; Hjelle SM; Eide GE; Gjertsen BT; Pfeffer F; Hovland R BJS Open; 2024 Jan; 8(1):. PubMed ID: 38242575 [TBL] [Abstract][Full Text] [Related]
38. Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer. Chen G; Peng J; Xiao Q; Wu HX; Wu X; Wang F; Li L; Ding P; Zhao Q; Li Y; Wang D; Shao Y; Bao H; Pan Z; Ding KF; Cai S; Wang F; Xu RH J Hematol Oncol; 2021 May; 14(1):80. PubMed ID: 34001194 [TBL] [Abstract][Full Text] [Related]
39. Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer. Reinert T; Henriksen TV; Christensen E; Sharma S; Salari R; Sethi H; Knudsen M; Nordentoft I; Wu HT; Tin AS; Heilskov Rasmussen M; Vang S; Shchegrova S; Frydendahl Boll Johansen A; Srinivasan R; Assaf Z; Balcioglu M; Olson A; Dashner S; Hafez D; Navarro S; Goel S; Rabinowitz M; Billings P; Sigurjonsson S; Dyrskjøt L; Swenerton R; Aleshin A; Laurberg S; Husted Madsen A; Kannerup AS; Stribolt K; Palmelund Krag S; Iversen LH; Gotschalck Sunesen K; Lin CJ; Zimmermann BG; Lindbjerg Andersen C JAMA Oncol; 2019 Aug; 5(8):1124-1131. PubMed ID: 31070691 [TBL] [Abstract][Full Text] [Related]
40. Synchronous ovarian and endometrial cancer--an international multicenter case-control study. Heitz F; Amant F; Fotopoulou C; Battista MJ; Wimberger P; Traut A; Fisseler-Eckhoff A; Harter P; Vandenput I; Sehouli J; Schmidt M; Kimmig R; du Bois R; du Bois A Int J Gynecol Cancer; 2014 Jan; 24(1):54-60. PubMed ID: 24300466 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]